Gastrointestinal dysmotility commonly follows thermal injuries, such as burns. This study aimed to investigate the effects and mechanisms of ...

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

This new article published in Genes & Diseases highlights the critical role of tRNA-derived small RNAs (tsRNAs) in digestive ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

Skipping breakfast due to lack of hunger, a busy schedule, or the belief that it helps with weight loss can lead to nutrient ...

Fight against cancer starts with understanding that knowledge is not just empowering but a survival tool. This holds for ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Without Ozempic's appetite-regulating effects, cravings for high-calorie, carbohydrate-rich foods may return. This can make ...

Topline results were announced from a phase 3 trial evaluating durvalumab in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) ...

Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...

This bloat is unbearably painful, thought Stephanie Dunne, 49, as she lay awake in bed hours after finishing dinner, still ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...